Over 300 CROs presently claim to possess the necessary capabilities to offer a wide range of preclinical / Roots Analysis

Given the complex R&D protocols and the increasing demand for clinical evidence of therapeutic benefit, there seems to be a lucrative opportunity for contract research providers engaged in the medical devices’ domain. In fact, since 2000, 150 new CROs have been established that offer a variety of cost-efficient services and solutions to medical device developers.

Key Inclusions

• A detailed review of the overall landscape of medical device CROs, along with information on year of establishment, company size, location of headquarters, type of service offered by [A] clinical service providers  (biostatistics, consulting, clinical operations, post marketing surveillance / studies, quality assurance, regulatory affairs management, reimbursement and training), [B] preclinical service providers (consulting, biocompatibility testing, materials characterization and analytical testing, preclinical trials support, sterility testing and microbiology testing, and training) and [C] stand-alone service providers (consulting, training, quality assurance, clinical operations, and regulatory affairs management).
• An elaborate discussion on the various guidelines established by major regulatory bodies for medical device approval across North America (the US, Canada and Mexico), Europe (France, Germany, Italy, Spain, the UK and rest of Europe), and Asia-Pacific and rest of the world (Australia, Brazil, China, India, Israel, Japan, New Zealand, Singapore, South Africa, South Korea, Taiwan, and Thailand). The report also features an insightful multi-dimensional, heat map analysis, featuring a comparison of the contemporary regulatory and reimbursement scenarios in key geographies across the globe.
• Elaborate profiles of key players that specialize in offering services for both clinical and preclinical stage development of medical devices. Each profile features an overview of the company, along with information on year of establishment, number of employees, location of headquarters, presence across key geographies, target therapeutic areas, financial details (if available), medical device focused service portfolio, and an informed future outlook.
• An analysis highlighting the key performance indicators used by sponsor companies to evaluate service providers engaged in this domain, based on information gathered via secondary research (for top-ten medical device players) and primary research.
• A competitive benchmarking, highlighting the key focus areas of small, mid-sized and large companies, comparing their existing capabilities within and beyond their respective peer groups, and providing a means for stakeholders to identify ways to gain a competitive advantage in the industry.
• A detailed brand positioning analysis of leading industry players (shortlisted on the basis of strength of service portfolio), highlighting the current perceptions regarding their proprietary brands across different device classes.

 

To order this 400+ page report, which features 240+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/medical-device-cros-market/226.html

 

The USD 15.7 billion (by 2030) financial opportunity within the antibody contract manufacturing market has been analyzed across the following segments:

• Phase of Development
• Clinical
• Preclinical

 

• Types of Preclinical Services Offered

• Biocompatibility testing
• Sterility and microbiology testing
• Material characterization and analytical services
• Others

 

• Types of Clinical Services Offered

• Clinical trial management
• Data management
• Regulatory affairs management
• Consulting
• Others

 

• Device Class

• Class I medical devices
• Class II medical devices
• Class III medical devices

 

• Target Therapeutic Area
• CNS disorders
• Cardiovascular disorders
• Oncological disorders
• Bone disorders
• Respiratory disorders
• Pain management disorders
• Ophthalmic disorders
• Psychological disorders
• Metabolic disorders
• Others

 

• Key Geographical Regions

• North America
• Europe
• Asia-Pacific
• Rest of the World

 

The “Medical Device CRO Market (2nd Edition), 2020-2030”. report features the following companies, which we identified to be key players in this domain:

• Avania (formerly known as Factory CRO)
• Charles River Laboratories
• Clinlogix
• CROMSOURCE
• CSSi LifeSciences™
• Eurofins Medical Device Testing
• genae
• IMARC Research
• IQVIA
• Medpace
• NAMSA
• Qserve Group
• Regulatory and Clinical Research Institute (now a part of Covance)
• WuXi AppTec

 

Table of Contents

 

1. Preface

2. Executive Summary

3. Introduction
 

4. Market Landscape
 

5. Regulatory and Reimbursement Landscape for Medical Devices
 

6. Company Profiles
 

7. Medical Device Developer and CRO Relationships: Key Value Drivers and Performance Indicators
 

8. Competitive Benchmarking
 

9. Brand Positioning of Key Industry Players
 

10. Clinical Trial Analysis
 

11. Mergers and Acquisitions
 

12. Survey Insights
 

13. Market Sizing and Forecast
 

14. Case Study: Impact of Coronavirus Outbreak

 

15. SWOT Analysis

 

16. Future Trends and Opportunities

 

17. Interview Transcripts

 

18. Appendix 1: Tabulated Data

 

19. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/medical-device-cros-market/226.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]